Nanoscale CAR Organization at the Immune Synapse Correlates with CAR-T Effector Functions

por Sajman, Julia, Yakovian, Oren, Unger Deshet, Naamit, Almog, Shaked, Horn, Galit, Waks, Tova, Globerson Levin, Anat, Sherman, Eilon
Publicado 2023

P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas

por Rousso-Noori, Liat, Mastandrea, Ignacio, Talmor, Shauli, Waks, Tova, Globerson Levin, Anat, Haugas, Maarja, Teesalu, Tambet, Alvarez-Vallina, Luis, Eshhar, Zelig, Friedmann-Morvinski, Dinorah
Publicado 2021

Proteolysis Targeting Chimeras for BTK Efficiently Inhibit B-Cell Receptor Signaling and Can Overcome Ibrutinib Resistance in CLL Cells

por Shorer Arbel, Yamit, Katz, Ben-Zion, Gabizon, Ronen, Shraga, Amit, Bronstein, Yotam, Kamdjou, Talia, Globerson Levin, Anat, Perry, Chava, Avivi, Irit, London, Nir, Herishanu, Yair
Publicado 2021

Comparing Intraperitoneal and Intravenous Personalized ErbB2CAR-T for the Treatment of Epithelial Ovarian Cancer

por Deshet-Unger, Naamit, Horn, Galit, Rawet-Slobodkin, Moran, Waks, Tova, Laskov, Ido, Michaan, Nadav, Raz, Yael, Bar, Vered, Zundelevich, Adi, Aharon, Sara, Turovsky, Lubov, Mallel, Giuseppe, Salpeter, Seth, Neev, Guy, Hollander, Kenneth Samuel, Katz, Ben-Zion, Grisaru, Dan, Globerson Levin, Anat
Publicado 2022